Saturday, June 14, 2025

Stroke Mimics

 

Stroke Mimics in the Emergency Room: Not All That Hemiparesis is Ischemia

A Comprehensive Review for Critical Care Practitioners

Dr Neeraj Manikath,Claude.ai


Abstract

Background: Stroke mimics account for 15-30% of patients presenting with acute neurological deficits suggestive of cerebrovascular accidents. The pressure to achieve rapid thrombolysis within therapeutic windows often leads to misdiagnosis and inappropriate treatment of stroke mimics, with potential for significant morbidity.

Objective: To provide critical care practitioners with systematic approaches to identify common stroke mimics, emphasizing hypoglycemia, Todd's paresis, conversion disorder, and hemiplegic migraine, while maintaining appropriate urgency for true stroke cases.

Methods: Comprehensive literature review of stroke mimics, focusing on diagnostic pearls, clinical decision-making tools, and evidence-based differentiation strategies.

Conclusions: A structured approach combining rapid bedside assessments, targeted investigations, and clinical suspicion indices can significantly reduce inappropriate thrombolysis while maintaining optimal stroke care pathways.

Keywords: Stroke mimics, thrombolysis, emergency medicine, hypoglycemia, Todd's paresis, conversion disorder, hemiplegic migraine


Introduction

The mantra "time is brain" has revolutionized acute stroke care, creating protocols that prioritize rapid assessment and treatment within narrow therapeutic windows. However, this urgency paradoxically increases the risk of treating stroke mimics—conditions that present with acute neurological deficits resembling cerebrovascular accidents but have entirely different etiologies and treatment approaches.

Stroke mimics represent a significant clinical challenge, comprising 15-30% of patients initially diagnosed with acute stroke.¹ The consequences of misdiagnosis are bidirectional: inappropriate thrombolysis of stroke mimics can cause hemorrhagic complications, while delayed recognition of true strokes results in missed therapeutic opportunities. This review focuses on four critical stroke mimics that emergency physicians and critical care specialists encounter most frequently, providing practical diagnostic approaches and clinical pearls.


The Clinical Dilemma

The Pressure Cooker Environment

Modern stroke protocols create a high-pressure environment where decisions must be made within minutes. The "door-to-needle" time of 60 minutes for intravenous thrombolysis and the expanding therapeutic windows for endovascular therapy have created systems optimized for speed. However, this rapid-fire approach can lead to diagnostic shortcuts that miss important stroke mimics.

The Cost of Misdiagnosis

Studies demonstrate that 4-15% of patients receiving thrombolytic therapy are ultimately diagnosed with stroke mimics.² The symptomatic intracranial hemorrhage rate in this population ranges from 0.5-2%, with mortality rates approaching 50% when hemorrhagic complications occur.³ Conversely, the number needed to treat for benefit in actual ischemic stroke is approximately 8-10 patients, highlighting the importance of accurate diagnosis.


Systematic Approach to Stroke Mimics

The MIMICS Framework

We propose the MIMICS framework for systematic evaluation:

  • Metabolic (hypoglycemia, hyperglycemia, hyponatremia)
  • Ictal/Post-ictal (Todd's paresis, non-convulsive status epilepticus)
  • Migraine (hemiplegic migraine, complicated migraine)
  • Infectious (encephalitis, meningitis, sepsis-associated encephalopathy)
  • Conversion/Functional (functional neurological disorder)
  • Structural (mass lesions, subdural hematoma)

Clinical Decision Points

Three critical decision points emerge in stroke mimic evaluation:

  1. Bedside Assessment Phase (0-15 minutes)
  2. Rapid Diagnostic Phase (15-45 minutes)
  3. Treatment Decision Phase (45-60 minutes)

Major Stroke Mimics: Clinical Pearls and Diagnostic Approaches

1. Hypoglycemia: The Great Imitator

Clinical Presentation

Hypoglycemia presents with focal neurological deficits in 3-4% of cases, most commonly manifesting as hemiparesis, aphasia, or altered consciousness.⁴ The neurological presentation often correlates with areas of highest metabolic demand or previous vascular compromise.

Pearl 1: The Glucose Gradient

Patients with recurrent hypoglycemia may develop neurological symptoms at higher glucose levels than expected. Consider "relative hypoglycemia" in diabetic patients with glucose levels of 70-90 mg/dL who present with acute neurological deficits.

Oyster 1: The Normoglycemic Trap

Normal glucose levels in the emergency department do not exclude recent hypoglycemia as the cause of persistent neurological deficits. Hypoglycemic hemiparesis can persist for hours after glucose normalization, particularly in elderly patients or those with diabetes.

Hack 1: The Dextrose Challenge

In patients with suspected hypoglycemic stroke mimic and glucose levels <100 mg/dL, administer 25-50g dextrose and reassess neurological function within 15-30 minutes. Rapid improvement strongly suggests hypoglycemic etiology.

Diagnostic Approach

  • Immediate bedside glucose measurement
  • Review of diabetes medications and recent oral intake
  • Consider C-peptide and insulin levels if factitious hypoglycemia suspected
  • Neuroimaging to exclude concurrent stroke in diabetic patients

Treatment Considerations

  • Avoid thrombolysis in patients with glucose <50 mg/dL pending response to dextrose
  • Monitor for rebound hypoglycemia, especially with long-acting insulin or sulfonylureas
  • Consider continuous glucose infusion rather than bolus dextrose in severe cases

2. Todd's Paresis: Post-Ictal Paralysis

Clinical Presentation

Todd's paresis occurs in 0.7-13% of patients following seizures, presenting as transient focal weakness lasting minutes to hours (rarely >48 hours).⁵ The weakness typically affects the body part involved in focal seizure activity.

Pearl 2: The Seizure History Paradox

Absence of witnessed seizure activity does not exclude Todd's paresis. Up to 30% of patients with post-ictal deficits have no clear seizure history, particularly in cases of subtle focal seizures or nocturnal seizures.

Oyster 2: The Bilateral Presentation

Todd's paresis can present bilaterally, mimicking basilar artery occlusion. Look for subtle asymmetry, as true bilateral Todd's paresis is rare and should prompt consideration of non-convulsive status epilepticus.

Hack 2: The EEG Window

Request stat EEG within 2 hours of presentation. Post-ictal slowing in the region corresponding to weakness supports Todd's paresis diagnosis. Conversely, normal EEG in the acute setting makes post-ictal etiology less likely.

Diagnostic Approach

  • Detailed history from witnesses, family, or EMS
  • Search for seizure risk factors: prior epilepsy, recent medication changes, sleep deprivation, alcohol withdrawal
  • Stat EEG if available within therapeutic window
  • Consider non-contrast CT to exclude structural causes
  • Serum lactate and prolactin levels (limited utility in ED setting)

Treatment Considerations

  • Avoid thrombolysis in patients with witnessed seizure and corresponding focal deficits
  • Consider bridging with EEG monitoring for unclear cases within therapeutic window
  • Treat underlying seizure disorder and precipitating factors

3. Conversion Disorder: Functional Neurological Symptoms

Clinical Presentation

Functional neurological disorder (conversion disorder) accounts for 1-4% of stroke mimics but up to 20-30% in younger demographics.⁶ Presentations include hemiparesis, sensory deficits, speech disturbances, and movement disorders.

Pearl 3: The Inconsistency Pattern

Functional weakness demonstrates internal inconsistency on examination. Look for "breakaway weakness" where initial strength gives way suddenly, inconsistent weakness patterns, and preservation of automatic movements.

Oyster 3: The Organic Overlap

Functional symptoms can coexist with organic disease. A history of stroke or other neurological conditions does not exclude functional overlay, and functional symptoms may be triggered by medical illness or hospitalization stress.

Hack 3: The Hoover Sign

Test hip extension strength while the patient lies supine. In functional weakness, pressing down on the unaffected leg while asking the patient to lift the "weak" leg often results in detectable downward pressure from the affected leg—a sign of intact motor pathways.

Clinical Examination Techniques

  • Collapsing weakness: Sudden loss of resistance during strength testing
  • Inconsistent sensory deficits: Non-anatomical sensory loss patterns
  • Tremor entrainment: Functional tremors change frequency when attention is directed elsewhere
  • Deliberate slowness: Exaggerated slowness of movements with excessive effort

Treatment Considerations

  • Avoid thrombolysis based on positive functional signs
  • Consider psychiatric consultation and stress-related precipitants
  • Approach with empathy rather than confrontation
  • Rule out organic causes thoroughly, as misdiagnosis carries significant liability

4. Hemiplegic Migraine: The Vascular Mimic

Clinical Presentation

Hemiplegic migraine affects 0.01% of the population but presents diagnostic challenges due to its stroke-like presentation with unilateral weakness, sensory symptoms, and speech disturbances.⁷ Symptoms typically precede or accompany headache but may occur without headache (silent migraine).

Pearl 4: The Progressive March

Unlike stroke, hemiplegic migraine symptoms often demonstrate a characteristic "march" progression, spreading from one body part to another over minutes to hours. This spreading pattern resembles cortical spreading depression rather than vascular territory involvement.

Oyster 4: The Age Factor

While hemiplegic migraine typically begins in adolescence or young adulthood, first episodes can occur at any age. Consider hemiplegic migraine even in older adults with strong migraine history and atypical presentations.

Hack 4: The Family History Clue

Familial hemiplegic migraine (FHM) accounts for 50% of cases. A detailed family history of similar episodes, even if not previously diagnosed, can provide crucial diagnostic information and may be obtained from relatives during the evaluation period.

Diagnostic Approach

  • Comprehensive headache history including family history
  • Assessment of typical migraine features: photophobia, phonophobia, nausea
  • Consider MRI with DWI to exclude stroke if clinical suspicion high
  • Genetic testing available for familial forms but not practical in acute setting

Treatment Considerations

  • Thrombolysis contraindicated in hemiplegic migraine
  • Avoid triptans during hemiplegic episodes due to risk of prolonged aura
  • Consider magnesium sulfate, antiemetics, and supportive care
  • Prophylactic therapy may be indicated for frequent episodes

Advanced Diagnostic Strategies

Neuroimaging Considerations

CT vs MRI Decision Making

  • Non-contrast CT: Rapid, excludes hemorrhage, limited sensitivity for early ischemic changes
  • CT Perfusion: Can differentiate hypoperfusion patterns in stroke vs. stroke mimics
  • MR DWI: Gold standard for acute ischemic stroke, but may show restricted diffusion in some mimics (hypoglycemia, seizures)

Pearl 5: The DWI Pitfall

Restricted diffusion on DWI is not pathognomonic for stroke. Hypoglycemia, seizures, and migraine can cause transient DWI changes. Clinical correlation remains paramount.

Laboratory Investigations

Targeted Laboratory Panel

  • Immediate: Glucose, basic metabolic panel, complete blood count
  • Secondary: Liver function tests, coagulation studies, toxicology screen
  • Specialized: Thiamine level, ammonia, arterial blood gas in selected cases

Hack 5: The Lactate Level

Elevated serum lactate (>2.5 mmol/L) within 6 hours may support post-ictal state, though sensitivity and specificity are limited. More useful as part of clinical pattern recognition.


Risk Stratification and Decision Tools

The ABCD² Score Modification

While designed for TIA risk stratification, a modified approach can help identify stroke mimic probability:

High Mimic Risk (Consider Alternative Diagnosis):

  • Age <50 years with atypical presentation
  • Blood glucose <70 or >300 mg/dL
  • Clinical features inconsistent with vascular territory
  • Duration of symptoms with fluctuating course
  • Diabetes with poor glycemic control

The FLAIR Score for Functional Symptoms

Functional features present Language preservation despite apparent aphasia Asymmetry in weakness patterns Inconsistent examination findings Rapid fluctuation in symptoms

Score ≥3 suggests functional etiology requiring careful evaluation before thrombolysis.


Management Algorithms

Algorithm 1: Hypoglycemia Evaluation

Acute neurological deficit + Glucose <100 mg/dL
↓
Administer 25-50g dextrose IV
↓
Reassess at 15 and 30 minutes
↓
Improvement: Likely hypoglycemic → Continue glucose management
No improvement: Consider concurrent stroke → Proceed with stroke workup

Algorithm 2: Post-Ictal Assessment

Acute neurological deficit + Seizure history/suspicion
↓
Stat EEG if available
↓
Post-ictal changes present: Likely Todd's paresis → Observe
Normal EEG: Consider stroke workup
Ongoing seizure activity: Treat status epilepticus

Quality Improvement and Error Prevention

System-Level Interventions

The Stroke Mimic Champion

Designate experienced clinicians as "stroke mimic champions" who can be consulted for challenging cases within the therapeutic window. This provides additional expert input without significantly delaying care.

Hack 6: The Parallel Process

Implement parallel processing where stroke workup proceeds while simultaneously evaluating for mimics. This approach maintains therapeutic urgency while building diagnostic confidence.

Documentation Standards

Standardize documentation of stroke mimic evaluation including:

  • Specific clinical features supporting or refuting stroke diagnosis
  • Alternative diagnoses considered
  • Risk-benefit analysis of thrombolytic therapy
  • Consultant recommendations when obtained

Educational Initiatives

Simulation Training

Regular simulation exercises focusing on stroke mimic scenarios improve diagnostic accuracy and decision-making under time pressure. Include cases with ambiguous presentations requiring complex risk-benefit analyses.

Case-Based Learning

Monthly case conferences reviewing stroke mimic cases, including near-miss events and diagnostic errors, enhance institutional learning and prevent recurrent mistakes.


Special Populations

Pediatric Considerations

Stroke mimics are proportionally more common in pediatric populations, with seizures, migraine, and metabolic disorders predominating. Standard adult stroke protocols may not apply, requiring modified approaches.

Elderly Patients

Polypharmacy, multiple comorbidities, and baseline cognitive impairment complicate stroke mimic diagnosis in elderly patients. Pay particular attention to medication-induced hypoglycemia and delirium mimicking stroke.

Patients with Disabilities

Baseline neurological deficits can mask or mimic new stroke symptoms. Establish clear baseline function and focus on changes from baseline rather than absolute deficits.


Medico-Legal Considerations

Documentation Requirements

Thorough documentation of stroke mimic evaluation protects against liability while ensuring quality care. Include:

  • Timeline of symptom evolution
  • Specific examination findings
  • Diagnostic reasoning process
  • Risk-benefit analysis for treatment decisions

Informed Consent

When stroke mimic diagnosis is suspected but not certain, informed consent discussions should address:

  • Diagnostic uncertainty
  • Risks of treatment vs. no treatment
  • Alternative diagnoses being considered
  • Follow-up plans

Future Directions

Artificial Intelligence Applications

Machine learning algorithms show promise in stroke mimic identification, potentially reducing diagnostic errors. However, clinical judgment remains essential for complex cases requiring nuanced decision-making.

Biomarker Development

Novel biomarkers specific for stroke vs. mimics are under investigation, including:

  • Neuron-specific enolase patterns
  • Inflammatory markers
  • Metabolomic profiles

Point-of-Care Testing

Rapid point-of-care tests for metabolic disorders and drug levels may improve stroke mimic diagnosis in the acute setting.


Conclusion

Stroke mimics represent a critical diagnostic challenge in emergency medicine, requiring a balance between therapeutic urgency and diagnostic accuracy. The conditions discussed—hypoglycemia, Todd's paresis, conversion disorder, and hemiplegic migraine—account for a significant proportion of stroke mimics and require specific diagnostic approaches.

Key takeaways for clinical practice include:

  1. Systematic Approach: Use structured frameworks like MIMICS to ensure comprehensive evaluation
  2. Rapid Assessment: Implement bedside tests and targeted investigations within therapeutic windows
  3. Clinical Judgment: Maintain high clinical suspicion while avoiding diagnostic anchoring
  4. Risk Stratification: Use validated tools and clinical pearls to stratify stroke mimic probability
  5. Quality Improvement: Implement system-level interventions to reduce diagnostic errors

The goal is not to delay stroke treatment but to enhance diagnostic accuracy within existing time constraints. This requires ongoing education, system improvements, and a commitment to evidence-based practice that protects patients from both missed strokes and inappropriate thrombolysis.

As stroke care continues to evolve with expanding therapeutic windows and new treatment modalities, the importance of accurate stroke mimic diagnosis will only increase. Critical care practitioners must remain vigilant, knowledgeable, and systematic in their approach to these challenging cases.


References

  1. Liberman AL, Prabhakaran S. Stroke chameleons and stroke mimics in the emergency department. Curr Neurol Neurosci Rep. 2017;17(2):15.

  2. Zinkstok SM, Engelter ST, Gensicke H, et al. Safety of thrombolysis in stroke mimics: results from a multicenter cohort study. Stroke. 2013;44(4):1080-1084.

  3. Chernyshev OY, Martin-Schild S, Albright KC, et al. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia. Neurology. 2010;74(17):1340-1345.

  4. Kang EG, Jeon SJ, Choi SS, Song CJ, Yu IK. Diffusion MR imaging of hypoglycemic encephalopathy. AJNR Am J Neuroradiol. 2010;31(3):559-564.

  5. Todd RB. Clinical lectures on paralysis, certain diseases of the brain, and other affections of the nervous system. London: John Churchill; 1854.

  6. Stone J, Carson A, Duncan R, et al. Which neurological diseases are most likely to be associated with "symptoms unexplained by organic disease". J Neurol. 2012;259(1):33-38.

  7. Russell MB, Ducros A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol. 2011;10(5):457-470.

  8. Waqas M, Rai AT, Vakharia K, et al. Effect of definition and methods on estimates of prevalence of large vessel occlusion in acute ischemic stroke: a systematic review and meta-analysis. J Neurointerv Surg. 2020;12(8):732-738.

  9. Kamal N, Sheng S, Xian Y, et al. Delays in door-to-needle times and their impact on treatment time and outcomes in get with the guidelines-stroke. Stroke. 2017;48(4):946-954.

  10. Tsivgoulis G, Alexandrov AV, Chang J, et al. Safety and outcomes of intravenous thrombolysis in stroke mimics: a 6-year, single-care center study and a pooled analysis of reported series. Stroke. 2011;42(6):1771-1774.

No comments:

Post a Comment

Hidden Adrenal Insufficiency in the ICU

  Hidden Adrenal Insufficiency in the ICU: Who to Test, Who to Treat Beyond Random Cortisol—What Does Recent Evidence Say? Dr Neeraj Manikat...